Press Releases | Senate Committee On Aging

Mar. 11

Majority Press

El presidente del Comité Rick Scott expone el peligroso control de la China comunista sobre el suministro de medicinas de Estados Unidos; Destaca la Ley de CLEAR LABELS para aumentar la transparencia

WASHINGTON, D.C. – El Senador Rick Scott, presidente del Comité Especial del Senado de EE.UU para asuntos de la vejez dirigió una audiencia titulada “Dependencia extranjera: Cómo...

Mar. 11

Majority Press

Chairman Rick Scott Exposes Communist China’s Dangerous Grip on America’s Medicine Supply; Highlights CLEAR LABELS Act to Increase Transparency

WASHINGTON, D.C. – Today, Chairman Rick Scott led a hearing entitled “Foreign Dependence: How China Captured America’s Drug Supply” to examine how Communist China has pursued...

Mar. 11

Joint Press

Chairman Scott, Ranking Member Gillibrand Set Hearing to Expose China’s Control of America’s Drug Supply

WASHINGTON, D.C. – On Wednesday, March 11, Chairman Rick Scott and Ranking Member Kirsten Gillibrand will convene a hearing entitled “Foreign Dependence: How China Captured...

Mar. 10

Joint Press

El presidente del Comité Scott y la miembro de alto rango Gillibrand fijan audiencia para exponer el control de China en el suministro de drogas estadounidense

WASHINGTON, D.C. – El Miércoles, 11 de Marzo, el presidente del Comité Especial del Senado de EE.UU para asuntos de la vejez, Rick Scott y la miembro de alto rango Kirsten...

Mar. 06

Majority Press

Chairman Rick Scott, Sen. Mark Kelly Lead Bipartisan Resolution Designating March 5th as National Slam the Scam Day

WASHINGTON, D.C. – Today, Chairman Rick Scott and Senator Mark Kelly announced the introduction of their resolution to designate March 5th as National Slam the Scam Day to raise...

Mar. 05

Majority Press

Chairman Rick Scott’s CLEAR LABELS Act Garners Bicameral Support with Rep. McCormick in the U.S. House

WASHINGTON, D.C. – Today, Chairman Rick Scott’s bipartisan Consumer Labeling for Enhanced API Reporting and Legitimate Accountability for Base Entity Listings (CLEAR LABELS) Act...

Mar. 04

Joint Press

Chairman Scott, Ranking Member Gillibrand Press America’s Pharmacies on U.S. Drug Supply Chain and Country-of-Origin Labeling for Foreign-Made Drugs

WASHINGTON, D.C. – Today, Chairman Rick Scott and Ranking Member Kirsten Gillibrand of the U.S. Senate Special Committee on Aging sent a letter to the chief executive officers of...

Feb. 26

Majority Press

El presidente del Comité Rick Scott aborda los obstáculos regulatorios que retrasan los tratamientos de enfermedades raras y limitan el acceso de los pacientes a la innovación

WASHINGTON, D.C. – El Senador Rick Scott, presidente del Comité Especial del Senado de EE.UU para asuntos de la vejez dirigió una audiencia titulada “Del regulador al bloqueo: Cómo...

Feb. 26

Majority Press

Chairman Rick Scott Addresses Regulatory Hurdles Delaying Rare Disease Treatments and Limiting Patient Access to Innovation

WASHINGTON, D.C. – Today, Chairman Rick Scott led a hearing entitled “From Regulator to Roadblock: How FDA Bureaucracy Stifles Innovation.” This hearing examined how regulatory...

Feb. 25

Joint Press

El presidente del Comité Scott y la miembro de alto rango Gillibrand examinarán los procesos regulatorios de la FDA, los retrasos en el tratamiento de enfermedades raras y la necesidad de mejorar el acceso de los pacientes a la innovación

WASHINGTON, D.C. – El Jueves, 26 de Febrero, el presidente del Comité Especial del Senado de EE.UU para asuntos de la vejez, Rick Scott y la miembro de alto rango Kirsten...

Feb. 25

Joint Press

Chairman Scott, Ranking Member Gillibrand to Examine FDA Regulatory Processes, Rare Disease Treatment Delays, and the Need to Improve Patient Access to Innovation

WASHINGTON, D.C. – On Thursday, February 26, Chairman Rick Scott and Ranking Member Kirsten Gillibrand will convene a hearing entitled “From Regulator to Roadblock: How FDA...

Feb. 19

Joint Press

Chairman Rick Scott Sends Letter to Secretary Hegseth on Securing Generic Drug Supply for Service Members and Veterans

WASHINGTON, D.C. – Yesterday, Chairman Rick Scott and Ranking Member Kirsten Gillibrand sent a letter to Department of War Secretary Pete Hegseth requesting information on efforts...

Feb. 13

Majority Press

Chairman Rick Scott to Convene Hearing on FDA Regulatory Processes, Rare Disease Treatment Delays, and Opportunities to Improve Patient Access to Innovation

On Thursday, February 26, Chairman Rick Scott of the U.S. Senate Special Committee on Aging will convene a hearing entitled “From Regulator to Roadblock: How FDA Bureaucracy...

Feb. 11

Majority Press

El presidente del Comité Rick Scott expone cómo la burocracia de Washington está perjudicando a los pacientes y socavando la sanidad

WASHINGTON, D.C. – El Senador Rick Scott, presidente del Comité Especial del Senado de EE.UU para asuntos de la vejez dirigió una audiencia titulada “Doctores están fuera: Cómo las...

Feb. 11

Majority Press

Chairman Rick Scott Exposes How Washington’s Red Tape is Harming Patients, Undermining Health Care

WASHINGTON, D.C. – Today, Chairman Rick Scott led a hearing entitled “The Doctor Is Out: How Washington’s Rules Drove Physicians Out of Medicine” examining how burdensome federal...

Feb. 10

Joint Press

El presidente del Comité Scott y la miembro de alto rango Gillibrand liderarán una audiencia sobre cómo el agotamiento médico está poniendo en peligro la atención sanitaria de los pacientes

WASHINGTON, D.C. – El Miércoles, 11 de Febrero, el presidente del Comité Rick Scott y la miembro de alto rango Kirsten Gillibrand del Comité Especial del Senado de EE.UU para...

Feb. 10

Joint Press

Chairman Scott, Ranking Member Gillibrand to Hold Hearing on How Physician Burnout is Jeopardizing Patients’ Health Care

WASHINGTON, D.C. – Tomorrow, Wednesday, February 11, Chairman Rick Scott and Ranking Member Kirsten Gillibrand of the U.S. Senate Special Committee on Aging will convene a hearing...

Feb. 05

Joint Press

Chairman Scott, Ranking Member Gillibrand Introduce CLEAR LABELS Act to Protect American Patients Through Drug Origin Transparency and Stronger Supply Chain Oversight

WASHINGTON, D.C. – Today, Chairman Rick Scott and Ranking Member Kirsten Gillibrand introduced the Consumer Labeling for Enhanced API Reporting and Legitimate Accountability for...

Jan. 29

Majority Press

Chairman Rick Scott Calls for Transparency of Foreign-Made Generic Drugs, Announces CLEAR LABELS Act to Require Country-of-Origin Labeling

WASHINGTON, D.C. – Today, Chairman Rick Scott led a hearing entitled “Truth in Labeling: Americans Deserve to Know Where Their Drugs Come From,” in which he exposed the serious...

Jan. 29

Majority Press

El presidente del Comité Rick Scott pide transparencia en los medicamentos genéricos fabricados en el extranjero y anuncia que la Ley CLEAR LABELS exigirá el etiquetado por país de origen

WASHINGTON, D.C. – El Senador Rick Scott, presidente del Comité Especial del Senado de EE.UU para asuntos de la vejez dirigió una audiencia titulada “Veracidad en el etiquetado:...

PressREleases

El presidente del Comité Rick Scott expone el peligroso control de la China comunista sobre el suministro de medicinas de Estados Unidos; Destaca la Ley de CLEAR LABELS para aumentar la transparencia

Chairman Rick Scott Exposes Communist China’s Dangerous Grip on America’s Medicine Supply; Highlights CLEAR LABELS Act to Increase Transparency

Chairman Scott, Ranking Member Gillibrand Set Hearing to Expose China’s Control of America’s Drug Supply

El presidente del Comité Scott y la miembro de alto rango Gillibrand fijan audiencia para exponer el control de China en el suministro de drogas estadounidense

Chairman Rick Scott, Sen. Mark Kelly Lead Bipartisan Resolution Designating March 5th as National Slam the Scam Day

Chairman Rick Scott’s CLEAR LABELS Act Garners Bicameral Support with Rep. McCormick in the U.S. House

Chairman Scott, Ranking Member Gillibrand Press America’s Pharmacies on U.S. Drug Supply Chain and Country-of-Origin Labeling for Foreign-Made Drugs

El presidente del Comité Rick Scott aborda los obstáculos regulatorios que retrasan los tratamientos de enfermedades raras y limitan el acceso de los pacientes a la innovación

Chairman Rick Scott Addresses Regulatory Hurdles Delaying Rare Disease Treatments and Limiting Patient Access to Innovation

El presidente del Comité Scott y la miembro de alto rango Gillibrand examinarán los procesos regulatorios de la FDA, los retrasos en el tratamiento de enfermedades raras y la necesidad de mejorar el acceso de los pacientes a la innovación

Chairman Scott, Ranking Member Gillibrand to Examine FDA Regulatory Processes, Rare Disease Treatment Delays, and the Need to Improve Patient Access to Innovation

Chairman Rick Scott Sends Letter to Secretary Hegseth on Securing Generic Drug Supply for Service Members and Veterans

Chairman Rick Scott to Convene Hearing on FDA Regulatory Processes, Rare Disease Treatment Delays, and Opportunities to Improve Patient Access to Innovation

El presidente del Comité Rick Scott expone cómo la burocracia de Washington está perjudicando a los pacientes y socavando la sanidad

Chairman Rick Scott Exposes How Washington’s Red Tape is Harming Patients, Undermining Health Care

El presidente del Comité Scott y la miembro de alto rango Gillibrand liderarán una audiencia sobre cómo el agotamiento médico está poniendo en peligro la atención sanitaria de los pacientes

Chairman Scott, Ranking Member Gillibrand to Hold Hearing on How Physician Burnout is Jeopardizing Patients’ Health Care

Chairman Scott, Ranking Member Gillibrand Introduce CLEAR LABELS Act to Protect American Patients Through Drug Origin Transparency and Stronger Supply Chain Oversight

Chairman Rick Scott Calls for Transparency of Foreign-Made Generic Drugs, Announces CLEAR LABELS Act to Require Country-of-Origin Labeling

El presidente del Comité Rick Scott pide transparencia en los medicamentos genéricos fabricados en el extranjero y anuncia que la Ley CLEAR LABELS exigirá el etiquetado por país de origen

Press
REleases